Sagimet Biosciences has a total of 140 patents globally, out of which 82 have been granted. Of these 140 patents, 77% patents are active. United States Of America is where Sagimet Biosciences has filed the maximum number of patents, followed by Japan and Australia. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Sagimet Biosciences.
Sagimet Biosciences was founded in 2007 by Lucas Pelkmans and Urs Greber. Sagimet Biosciences operates as a clinical-stage biopharmaceutical company. The Company develops novel therapeutics to treat diseases such as non-alcoholic steatohepatitis (NASH) and various cancers. Sagimet Biosciences serves clients in the United States.
Do read about some of the most popular patents of Sagimet Biosciences which have been covered by us in this article and also you can find Sagimet Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sagimet Biosciences patent portfolio.
How many patents does the CEO of Sagimet Biosciences have?
The CEO, George Kemble has 0 patents.
How many patents does Sagimet Biosciences have?
Sagimet Biosciences has a total of 140 patents globally. These patents belong to 21 unique patent families. Out of 140 patents, 109 patents are active.
How Many Patents did Sagimet Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Sagimet Biosciences Applications Filed||Sagimet Biosciences Patents Granted|
How many Sagimet Biosciences patents are Alive/Dead?
How Many Patents did Sagimet Biosciences File in Different Countries?
Countries in which Sagimet Biosciences Filed Patents
|United States Of America||21|
|Hong Kong (S.A.R.)||7|
Where are Research Centers of Sagimet Biosciences Patents Located?
10 Best Sagimet Biosciences Patents
WO2012122391A1 is the most popular patent in the Sagimet Biosciences portfolio. It has received 70 citations so far from companies like Galderma Research & Development and 3-V Biosciences.
Below is the list of 10 most cited patents of Sagimet Biosciences:
|Publication Number||Citation Count|
What Percentage of Sagimet Biosciences US Patent Applications were Granted?
Sagimet Biosciences (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 11 have been granted leading to a grant rate of 78.57%.
Below are the key stats of Sagimet Biosciences patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Sagimet Biosciences?
|Law Firm||Total Applications||Success Rate|
EXCLUSIVE INSIGHTS COMING SOON!